Survival analysis from TCGA database showed that high MAFG expression predicted poor progression-free and disease-specific survival rates in patients with PCa (Figures 6H, I), thereby revealing the clinical significance of MAFG in PCa. The gene discussed is MAFG; the disease is posterior cortical atrophy.